New ZEISS Celldiscoverer 7

New ZEISS Celldiscoverer 7 for Live Cell Imaging

JENA/Germany, 2016-11-02.

Today, ZEISS introduces a new system for automated microscopy in life sciences research. ZEISS Celldiscoverer 7 combines the user-friendly automation features of a boxed microscope with the image quality and flexibility of a classic inverted research microscope. Scientists acquire better data in shorter times with 2D or 3D cell cultures, tissue sections or small model organisms.

In contrast to other boxed microscopes with limited flexibility, ZEISS Celldiscoverer 7 can be adapted to a whole range of tasks and applications. The system comes with various incubation and detection options and can be tailored to the individual needs of research labs. Users can choose from a selected range of microscope cameras for even the most demanding live cell experiments and rapid time-lapse recordings. In particular, the new ZEISS Axiocam 512 mono microscope camera with highest 12 MP resolution and a large field of view allows fluorescence screening applications with high throughput.

The new optical design of ZEISS Celldiscoverer 7 together with advanced automatic calibration routines helps researchers to achieve reproducible high quality data even from complex long-term, time-lapse imaging experiments. A new hardware-based autofocus not only finds and keeps the focus automatically, but also detects the thickness and optical properties of the sample carrier. This information is then used to adapt the unique ZEISS Autocorr objectives to deliver the best image quality possible.

ZEISS Celldiscoverer 7 is controlled by ZEN imaging software that provides additional key features for the automated microscope system. The dedicated software package from ZEISS for example calculates the maximal scanning area for any sample carrier automatically and actively protects the objective from collisions with your sample vessel or other hardware components. ZEISS ZEN 2.3 offers convenient experiment setup with user-friendly automation wizards, large-data acquisition, and data processing in 2D and 3D. The newly developed optics of ZEISS Celldiscoverer 7 in combination with rapid GPU-based deconvolution algorithms allow scientists to extract a maximum of information from their samples, artifact-free and in the shortest time possible. As ZEN supports open interfaces and scripting, ZEISS Celldiscoverer 7 can be integrated in virtually every lab workflow. Experiment data is easily exported to a multitude of file formats and third-party image analysis software.

ZEISS Celldiscoverer 7 is the new reliable research platform that offers a unique combination of automation features in life science research. The system will be on display at the upcoming Neuroscience and ASCB annual meetings and is available for live demonstrations worldwide.

More details and contact are available on the website:

Often in life sciences research, the data you are after will only be revealed through multiple runs of experiments or complex assays. Automation and parallelization can be the only way to get there. Now, with Celldiscoverer 7, you can combine the easy-to-use automation of a boxed microscope with the image quality and flexibility of a classic inverted research microscope.

Rat primary cortical neuron culture. Deconvolved z-stack projection using GPU-based deconvolution. Antibody-staining of Class III beta-tubulin (Cy2), Nestin (Cy3) and DCX (Cy5). Nuclei DAPI-stained. Sample courtesy of H. Braun, LSM Bioanalytik GmbH, Magdeburg, Germany.

Press Contacts:

Dr. Johannes Amon
Carl Zeiss Microscopy GmbH
Phone: +49 89 90 9000-319
johannes .amon @zeiss .com


ZEISS is an internationally leading technology enterprise operating in the optics and optoelectronics industries. The ZEISS Group develops and distributes semiconductor manufacturing equipment, measuring technology, microscopes, medical technology, eyeglass lenses, camera and cine lenses, binoculars and planetarium technology. With its solutions, the company constantly advances the world of optics and helps shape technological progress. ZEISS is divided up into the four segments Semiconductor Manufacturing Technology, Research & Quality Technology, Medical Technology, and Vision Care/Consumer Optics. ZEISS is represented in over 40 countries and operates more than 30 production sites, over 50 sales and service locations and about 25 research and development facilities.

In fiscal year 2014/15 the company generated revenue approximating €4.5 billion with around 25,000 employees. Founded in 1846 in Jena, the company is headquartered in Oberkochen, Germany. Carl Zeiss AG is the strategic management holding company that manages the ZEISS Group. The company is wholly owned by the Carl Zeiss Stiftung (Carl Zeiss Foundation).

Further information at


The Microscopy business group is the world's only one-stop manufacturer of light, X-ray and electron microscope systems. The portfolio compromises solutions and services for the life sciences and materials research as well as for industry, education and clinical practice. The business group is headquartered in Jena. Additional production and development sites are located in Oberkochen, Göttingen and Munich, as well as in Cambridge in the UK, and in Peabody, MA and Pleasanton, CA in the USA. The business group is allocated to the Research & Quality Technology segment. Around 5,900 employees work for the segment, generating revenue totaling €1.356 billion in fiscal year 2014/15.